Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class ASSE: 688266

Announcement on Voluntary Disclosure and Signing of Exclusive Marketing Service Agreement for Recombinant Human Thyroid Stimulating Hormone for Injection

· Issued by Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure and Signing of Exclusive Marketing Service Agreement for Recombinant Human Thyroid Stimulating Hormone for Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment